Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000425872 | SCV000518665 | benign | not specified | 2016-02-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001079847 | SCV000559562 | benign | Combined oxidative phosphorylation defect type 17 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316542 | SCV004017445 | benign | Prostate cancer, hereditary, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676441 | SCV005247898 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676441 | SCV000802222 | benign | not provided | 2017-09-15 | no assertion criteria provided | clinical testing |